UnitedHealth Group (NYSE:UNH) Shares Unloaded Rep. Lisa C. McClain

Posted by Defense World Staff on Aug 17th, 2025

Representative Lisa C. McClain (R-Michigan) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on June 24th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

Sold $1,001 – $15,000 in shares of Autoliv (NYSE:ALV) on 8/4/2025.
Sold $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 8/4/2025.
Sold $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 8/4/2025.
Sold $1,001 – $15,000 in shares of Arthur J. Gallagher & Co. (NYSE:AJG) on 8/4/2025.
Sold $1,001 – $15,000 in shares of SAP (NYSE:SAP) on 7/22/2025.
Purchased $1,001 – $15,000 in shares of XPO (NYSE:XPO) on 7/22/2025.
Purchased $1,001 – $15,000 in shares of Lithia Motors (NYSE:LAD) on 7/22/2025.
Sold $1,001 – $15,000 in shares of Sanofi (NASDAQ:SNY) on 7/22/2025.
Sold $1,001 – $15,000 in shares of Waters (NYSE:WAT) on 7/22/2025.
Purchased $1,001 – $15,000 in shares of Group 1 Automotive (NYSE:GPI) on 7/22/2025.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $304.02 on Friday. The firm’s 50 day simple moving average is $288.91 and its 200-day simple moving average is $396.85. The company has a market cap of $275.34 billion, a P/E ratio of 13.17, a price-to-earnings-growth ratio of 1.96 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business’s revenue was up 12.9% on a year-over-year basis. During the same period last year, the business earned $6.80 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company’s stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.28% of the stock is owned by company insiders.

Institutional Trading of UnitedHealth Group

Institutional investors and hedge funds have recently modified their holdings of the company. Parr Mcknight Wealth Management Group LLC raised its stake in UnitedHealth Group by 24.1% during the 2nd quarter. Parr Mcknight Wealth Management Group LLC now owns 25,772 shares of the healthcare conglomerate’s stock valued at $8,040,000 after purchasing an additional 5,004 shares during the last quarter. Headlands Technologies LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at $511,000. CANADA LIFE ASSURANCE Co increased its holdings in UnitedHealth Group by 7.1% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 1,189,542 shares of the healthcare conglomerate’s stock valued at $371,503,000 after buying an additional 79,311 shares during the period. 44 Wealth Management LLC increased its holdings in UnitedHealth Group by 41.7% in the 2nd quarter. 44 Wealth Management LLC now owns 2,140 shares of the healthcare conglomerate’s stock valued at $668,000 after buying an additional 630 shares during the period. Finally, Tower Research Capital LLC TRC increased its holdings in UnitedHealth Group by 25.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 51,501 shares of the healthcare conglomerate’s stock valued at $16,067,000 after buying an additional 10,291 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently commented on UNH. TD Securities reaffirmed a “hold” rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research report on Wednesday, May 14th. Finally, Raymond James Financial downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $366.52.

Read Our Latest Report on UNH

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.